Rubius Therapeutics, Inc. 8-K SEC Filings

Filed On	Filing
06 Apr 2023	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
03 Mar 2023	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Departure/Election of Directors or Officers; Compensation
22 Feb 2023	8-K: Other Events
06 Feb 2023	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Departure/Election of Directors or Officers; Compensation
21 Dec 2022	8-K: Completion of Acquisition or Disposition of Assets
14 Dec 2022	8-K: Termination of a Material Definitive Agreement
12 Dec 2022	8-K: Entry into a Material Definitive Agreement
02 Nov 2022	8-K: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation
17 Oct 2022	8-K: Departure/Election of Directors or Officers; Compensation
13 Oct 2022	8-K: Triggering Events That Accelerate a Financial Obligation
13 Sep 2022	8-K: Costs Associated with Exit or Disposal Activities; Other Events
12 Aug 2022	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Departure/Election of Directors or Officers; Compensation
09 Aug 2022	8-K: Results of Operations and Financial Condition
01 Aug 2022	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
14 Jul 2022	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
07 Jul 2022	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
24 May 2022	8-K: Termination of a Material Definitive Agreement; Regulation FD Disclosure
13 May 2022	8-K: Submission of Matters to a Vote of Security Holders
10 May 2022	8-K: Results of Operations and Financial Condition
08 Apr 2022	8-K: Regulation FD Disclosure; Other Events

Comments